date:Jan 23, 2014
e included weakness in dietary supplements and fish oil-based Omega-3 markets in the US, soft demand in Western food and beverage markets, and price pressures especially in vitamin E following weak demand in animal feed markets earlier in the year. DSM previously signalled these adverse conditions, but the impact through the end of the year was more pronounced than anticipated.
We achieved significant strategic progress in 2013, also demonstrated by an approximately 20% increase in full year EB